The long term effects of chemotherapy on the central nervous system

Journal of Biology

Volumn 5, Issue , 2006, Pages

  Duffner, Patricia K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL POPULATION; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; LEUKEMIA; LEUKOENCEPHALOPATHY; LONG TERM CARE; NEURAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POPULATION RISK; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; PATHOLOGY; REVIEW; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; COGNITION DISORDERS; HUMANS; TIME;

EID: 34447121459     PISSN: 14785854     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol51     Document Type: Short Survey

References (15)

1. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Dietrich R Han Y Yang M Mayer-Pröschel M Noble, J Biol 2006 5 22
2. Late effects of treatment on the intelligence of children with posterior fossa tumors. PK Duffner ME Cohen PRM Thomas, Cancer 1983 51 233 237 10.1002/1097-0142(19830115)51:2<233::AID-CNCR2820510211>3.0.CO;2-8 6821813
3. Medulloblastoma in childhood. Survival and functional results. JF Hirsch D Renier P Czernichow L Benveniste A Pierre-Kahn, Acta Neurochirurgica 1979 48 1 15 10.1007/BF01406016 495234
4. Advantages of 'total' resection of medulloblastoma and disadvantages of full head postoperative radiation therapy. AJ Raimondi T Tomita, Childs Brain 1979 5 550 551
5. Prospective intellectual testing in children with brain tumors. PK Duffner ME Cohen MS Parker, Ann Neurol 1988 23 575 579 10.1002/ana.410230608 3408238
6. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2 year results. RJ Packer LN Sutton TE Atkins J Radcliffe GR Bunin G D'Angio KR Siegel L Schut, J Neurosurg 1989 70 707 713 2709111
7. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. PK Duffner, Neurologist 2004 10 293 310 10.1097/01.nrl.0000144287.35993.96 15518596
8. Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group study. RJ Packer J Goldwein HS Nicholson LG Vezina JC Allen MD Ris K Muraszko LB Rorke WM Wara BH Cohen JM Boyett, J Clin Oncol 1999 17 2127 2136 10561268
9. Prospective chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. PK Duffner ME Horowitz JP Krischer HS Friedman PC Burger ME Cohen RA Sanford RK Mulhern HE James CR Freeman, N Engl J Med 1993 328 1725 1731 10.1056/NEJM199306173282401 8388548
10. Effects of different forms of central nervous prophylaxis on neuropsychologic function in childhood leukemia. JH Rowland OJ Glidewell RF Sibley JC Holland R Tull A Berman ML Brecher M Harris AS Glickman E Forman, J Clin Oncol 1984 2 1327 1335 6595350
11. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Peylan-Ramu DG Poplack PA Pizzo BT Adornato G DiChiro, N Engl J Med 1978 298 815 818 273143
12. CT abnormalities and altered methotrexate clearance in children with CNS leukemia. PK Duffner ME Cohen ML Brecher P Berger KL Parthasarathy S Bakshi LJ Ettinger A Freeman, Neurology 1984 34 229 233 6538016
13. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. DH Mahoney Jr JJ Shuster R Nitschke SJ Lauer CP Steuber N Winick B Camitta, J Clin Oncol 1998 16 1712 1722 9586883
14. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. S Rutkowski U Bode F Deinlein H Ottensmeier M Warmuth-Metz N Soerensen N Graf A Emser T Pietsch JE Wolff, N Engl J Med 2005 352 978 986 10.1056/NEJMoa042176 15758008
15. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. RK Mulhern SL Palmer WE Reddick JO Glass LE Kun J Taylor J Langston A Gajjar, J Clin Oncol 2001 19 472 479 11208841